# Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers

> **NCT07067775** · PHASE1 · COMPLETED · sponsor: **Jiangsu vcare pharmaceutical technology co., LTD** · enrollment: 18 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Vicagrel Capsules
- **DRUG:** Clopidogrel Tablets

## Key facts

- **NCT ID:** NCT07067775
- **Lead sponsor:** Jiangsu vcare pharmaceutical technology co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-05
- **Primary completion:** 2025-08-22
- **Final completion:** 2025-08-22
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07067775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07067775, "Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07067775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*